Développement d’actions de prévention du VIH, des hépatites et des infections sexuellement transmissibles chez les migrants consultant dans les missions France de médecins du monde

Pauti, M.-D.; Simonnot, Nathalie; Estecahandy, Pascale

doi:10.1016/j.medmal.2008.06.028

Cited by 5 publications

(8 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In addition, 20 articles (two Chinese [24,25], eight Japanese [26-33], one Icelandic [34], four Russian [35-38], two Turkish [39,40], one Czech [41], and two Taiwanese [42,43]) seemed relevant on the basis of the English abstracts, but were excluded as the abstracts alone did not yield enough information for review. One article was excluded because the same data were reported in two papers [44,45]. Of the 60 studies remaining, references lists were screened yielding an additional 106 potentially relevant records.…”

Section: Resultsmentioning

confidence: 99%

“…In most programs (9/12), screening was limited to HCV risk groups within the GP-patient population (specific migrant groups [46,47]; risk groups such as those with a history of IDU and recipients of blood transfusions before 1991 [70,72,73,75-78]). One program was carried out in a health care center that attracted people with poor access to health care, mostly migrants [44], and one was carried out in an area of low socioeconomic status [71]. In two of the 12 programs, individuals who were in the GP’s waiting room were approached and invited for screening [44,46], and five programs used media activities to attract individuals for screening.…”

Section: Resultsmentioning

confidence: 99%

“…One program was carried out in a health care center that attracted people with poor access to health care, mostly migrants [44], and one was carried out in an area of low socioeconomic status [71]. In two of the 12 programs, individuals who were in the GP’s waiting room were approached and invited for screening [44,46], and five programs used media activities to attract individuals for screening. Of the 12 studies, four reported that screening was free of cost [70,73,78,99], whereas the others did not report participants’ costs for screening.…”

Section: Resultsmentioning

confidence: 99%

“…Of the 12 studies, four reported that screening was free of cost [70,73,78,99], whereas the others did not report participants’ costs for screening. Only the screening program among people with poor access to health care offered the possibility of anonymous screening [44]. …”

Section: Resultsmentioning

confidence: 99%

“…The majority (9/12) of the programs focused solely on HCV screening. The three programs that screened predominantly migrants also included HBV screening [44,46,47]. …”

Section: Resultsmentioning

confidence: 99%

See 4 more Smart Citations

Outcomes of hepatitis C screening programs targeted at risk groups hidden in the general population: a systematic review

et al. 2014

View full text Add to dashboard Cite

BackgroundEffective screening programs are urgently needed to provide undiagnosed hepatitis C virus (HCV)-infected individuals with therapy. This systematic review of characteristics and outcomes of screening programs for HCV focuses on strategies to identify HCV risk groups hidden in the general population.MethodsWe conducted a comprehensive search of MEDLINE and EMBASE databases for articles published between 1991–2010, including studies that screened the general population using either a newly developed (nonintegrated) screening program or one integrated in existing health care facilities. Look-back studies, prevalence studies, and programs targeting high-risk groups in care (e.g., current drug users) were excluded.ResultsAfter reviewing 7052 studies, we identified 67 screening programs: 24 nonintegrated; 41 programs integrated in a variety of health care facilities (e.g., general practitioner); and 2 programs with both integrated and nonintegrated strategies. Together, these programs identified approximately 25,700 HCV-infected individuals. In general, higher HCV prevalence was found in programs in countries with intermediate to high HCV prevalence, in psychiatric clinics, and in programs that used a prescreening selection based on HCV risk factors. Only 6 programs used a comparison group for evaluation purposes, and 1 program used theory about effective promotion for screening. Comparison of the programs and their effectiveness was hampered by lack of reported data on program characteristics, clinical follow-up, and type of diagnostic test.ConclusionsA prescreening selection based on risk factors can increase the efficiency of screening in low-prevalence populations, and we need programs with comparison groups to evaluate effectiveness. Also, program characteristics such as type of diagnostic test, screening uptake, and clinical outcomes should be reported systematically.

show abstract

Section: Resultsmentioning

confidence: 99%

Section: Resultsmentioning

confidence: 99%

Section: Resultsmentioning

confidence: 99%

Section: Resultsmentioning

confidence: 99%

“…The majority (9/12) of the programs focused solely on HCV screening. The three programs that screened predominantly migrants also included HBV screening [44,46,47]. …”

Section: Resultsmentioning

confidence: 99%

See 3 more Smart Citations

Outcomes of hepatitis C screening programs targeted at risk groups hidden in the general population: a systematic review

et al. 2014

View full text Add to dashboard Cite

show abstract

988 Outcomes of Hepatitis C Screening Programs Targeted at Risk Groups Hidden in the General Population: A Systematic Review

Urbanus¹,

Zuure²,

Langendam³

et al. 2013

Journal of Hepatology

View full text Add to dashboard Cite

Background: Effective screening programs are urgently needed to provide undiagnosed hepatitis C virus (HCV)-infected individuals with therapy. This systematic review of characteristics and outcomes of screening programs for HCV focuses on strategies to identify HCV risk groups hidden in the general population. Methods: We conducted a comprehensive search of MEDLINE and EMBASE databases for articles published between 1991-2010, including studies that screened the general population using either a newly developed (nonintegrated) screening program or one integrated in existing health care facilities. Look-back studies, prevalence studies, and programs targeting high-risk groups in care (e.g., current drug users) were excluded. Results: After reviewing 7052 studies, we identified 67 screening programs: 24 nonintegrated; 41 programs integrated in a variety of health care facilities (e.g., general practitioner); and 2 programs with both integrated and nonintegrated strategies. Together, these programs identified approximately 25,700 HCV-infected individuals. In general, higher HCV prevalence was found in programs in countries with intermediate to high HCV prevalence, in psychiatric clinics, and in programs that used a prescreening selection based on HCV risk factors. Only 6 programs used a comparison group for evaluation purposes, and 1 program used theory about effective promotion for screening. Comparison of the programs and their effectiveness was hampered by lack of reported data on program characteristics, clinical follow-up, and type of diagnostic test. Conclusions: A prescreening selection based on risk factors can increase the efficiency of screening in low-prevalence populations, and we need programs with comparison groups to evaluate effectiveness. Also, program characteristics such as type of diagnostic test, screening uptake, and clinical outcomes should be reported systematically.

show abstract

How effective are approaches to migrant screening for infectious diseases in Europe? A systematic review

Seedat

Hargreaves

Nellums

et al. 2018

The Lancet Infectious Diseases

120

122

View full text Add to dashboard Cite

Rates of migration to Europe, and within Europe, have increased in recent years, with considerable implications for health systems. Migrants in Europe face a disproportionate burden of tuberculosis, HIV, and hepatitis B and C, yet experience a large number of barriers to accessing statutory health care on arrival. A better understanding of how to deliver effective and cost-effective screening, vaccination, and health services to this group is now crucial. We did a systematic review to document and assess the effectiveness and cost-effectiveness of approaches used for infectious diseases screening, and to explore facilitators and barriers experienced by migrants to accessing screening programmes. Following PRISMA guidelines, we searched Embase, PubMed, PsychINFO, the Cochrane Library, and Web of Science (1989 to July 1, 2015, updated on Jan 1, 2018), with no language restrictions, and systematically approached experts across the European Union (EU) for grey literature. Inclusion criteria were primary research studies assessing screening interventions for any infectious disease in the migrant (foreign-born) population residing in EU or European Economic Area (EEA) countries. Primary outcomes were the following effectiveness indicators: uptake of screening, coverage, infections detected, and treatment outcomes. Of 4112 unique records, 47 studies met our inclusion criteria, from ten European countries (Belgium, Denmark, France, Italy, the Netherlands, Norway, Spain, Sweden, Switzerland, and the UK) encompassing 248 402 migrants. We found that most European countries screening migrants focus on single diseases only-predominantly active or latent tuberculosis infection-and specifically target asylum seekers and refugees, with 22 studies reporting on other infections (including HIV and hepatitis B and C). An infection was detected in 3·74% (range 0·00-95·16) of migrants. Latent tuberculosis had the highest prevalence across all infections (median 15·02% [0·35-31·81]). Uptake of screening by migrants was high (median 79·50% [18·62-100·00]), particularly in primary health-care settings (uptake 96·77% [76·00-100·00]). However, in 24·62% (0·12-78·99) of migrants screening was not completed and a final diagnosis was not made. Pooled data highlight high treatment completion in migrants (83·79%, range 0·00-100·00), yet data were highly heterogeneous for this outcome, masking important disparities between studies and infections, with only 54·45% (35·71-72·27) of migrants with latent tuberculosis ultimately completing treatment after screening. Coverage of the migrant population in Europe is low (39·29% [14·53-92·50]). Data on cost-effectiveness were scarce, but suggest moderate to high cost-effectiveness of migrant screening programmes depending on migrant group and disease targeted. European countries have adopted a variety of approaches to screening migrants for infections; however, these are limited in scope to single diseases and a narrow subset of migrants, with low coverage. More emphasis must be placed on developing inno...

show abstract

Développement d’actions de prévention du VIH, des hépatites et des infections sexuellement transmissibles chez les migrants consultant dans les missions France de médecins du monde

Cited by 5 publications

References 0 publications

Outcomes of hepatitis C screening programs targeted at risk groups hidden in the general population: a systematic review

Outcomes of hepatitis C screening programs targeted at risk groups hidden in the general population: a systematic review

988 Outcomes of Hepatitis C Screening Programs Targeted at Risk Groups Hidden in the General Population: A Systematic Review

How effective are approaches to migrant screening for infectious diseases in Europe? A systematic review

Contact Info

Product

Resources

About